<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The potential anti-senescence gene Klotho (KL) has been recently found to participate in the progression of several different human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including breast, lung, and <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this current study, we identified KL as a candidate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene silenced through promoter hypermethylation in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>KL gene expression is found to be absent or reduced in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines (5/6, 83.3%), which can be reversed by treatment with demethylation agent <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi> (Aza), but not HDAC inhibitor <z:chebi fb="0" ids="46024">trichostatin A</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, KL expression is markedly downregulated in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> tissues when compared to the adjacent nontumor tissues (n=25, p&lt;0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>The methylation of the KL gene promoter was frequently detected in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> tissues (34/40, 85%) when compared with adjacent nontumor colon tissues </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, ectopic expression of KL led to the cell proliferation inhibition of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines via the induction of cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and S-phase cell cycle arrest </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together, our results suggest that KL is inactivated through promoter hypermethylation and potentially functions as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>